Roles for chemokines in liver disease

Gastroenterology

Volumn 147, Issue 3, 2014, Pages

  Marra, Fabio ^a   Tacke, Frank ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

HCV; Immune Regulation; Inflammatory Response; NASH

Indexed keywords

CCL1 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR7; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CXCL16 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADIPOSE TISSUE; ALCOHOL LIVER DISEASE; ARTICLE; CHOLESTATIC HEPATITIS; DENDRITIC CELL; FATTY LIVER; HEPATITIS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOCOMPETENT CELL; INSULIN RESISTANCE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; LIVER REGENERATION; MACROPHAGE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UPREGULATION; VIRUS HEPATITIS;

HCV; IMMUNE REGULATION; INFLAMMATORY RESPONSE; NASH;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CHEMOKINES; HEPATITIS; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84906535982     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.06.043     Document Type: Review

References (170)

1. H.W. Zimmermann, and F. Tacke Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis Inflamm Allergy Drug Targets 10 2011 509 536
2. I.F. Charo, and R.M. Ransohoff The many roles of chemokines and chemokine receptors in inflammation N Engl J Med 354 2006 610 621 (Pubitemid 43209108)
3. A. Zlotnik, and O. Yoshie Chemokines: a new classification system and their role in immunity Immunity 12 2000 121 127 (Pubitemid 30398626)
4. M. Mellado, J.M. Rodriguez-Frade, and S. Manes et al. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation Annu Rev Immunol 19 2001 397 421 (Pubitemid 32368041)
5. Y.H. Oo, S. Shetty, and D.H. Adams The role of chemokines in the recruitment of lymphocytes to the liver Dig Dis 28 2010 31 44
6. A.E. Proudfoot, T.M. Handel, and Z. Johnson et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines Proc Natl Acad Sci U S A 100 2003 1885 1890 (Pubitemid 36254543)
7. H.E. Wasmuth, F. Tacke, and C. Trautwein Chemokines in liver inflammation and fibrosis Semin Liver Dis 30 2010 215 225
8. T.J. Schall, and A.E. Proudfoot Overcoming hurdles in developing successful drugs targeting chemokine receptors Nat Rev Immunol 11 2011 355 363
9. R. Medzhitov, D.S. Schneider, and M.P. Soares Disease tolerance as a defense strategy Science 335 2012 936 941
10. E. Liaskou, D.V. Wilson, and Y.H. Oo Innate immune cells in liver inflammation Mediators Inflamm 2012 2012 949157
11. D.M. Dambach, L.M. Watson, and K.R. Gray et al. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse Hepatology 35 2002 1093 1103 (Pubitemid 34454006)
12. E. Seki, S. De Minicis, and C.H. Osterreicher et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 13 2007 1324 1332 (Pubitemid 350073596)
13. K.R. Karlmark, R. Weiskirchen, and H.W. Zimmermann et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis Hepatology 50 2009 261 274
14. N.V. Serbina, and E.G. Pamer Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 Nat Immunol 7 2006 311 317
15. F. Heymann, L. Hammerich, and D. Storch et al. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice Hepatology 55 2012 898 909
16. N. Nakamoto, H. Ebinuma, and T. Kanai et al. CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis Gastroenterology 142 2012 366 376
17. K.R. Karlmark, H.W. Zimmermann, and C. Roderburg et al. The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes Hepatology 52 2010 1769 1782
18. V. Racanelli, and B. Rehermann The liver as an immunological organ Hepatology 43 2006 S54 S62
19. M.J. Robertson Role of chemokines in the biology of natural killer cells J Leukoc Biol 71 2002 173 183
20. M.N. Ajuebor, Z. Wondimu, and C.M. Hogaboam et al. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis Am J Pathol 170 2007 1975 1988 (Pubitemid 47339271)
21. F. Geissmann, T.O. Cameron, and S. Sidobre et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids PLoS Biol 3 2005 e113
22. A. Wehr, C. Baeck, and F. Heymann et al. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis J Immunol 190 2013 5226 5236
23. Y.H. Oo, V. Banz, and D. Kavanagh et al. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver J Hepatol 57 2012 1044 1051
24. L. Hammerich, J.M. Bangen, and O. Govaere et al. Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis Hepatology 59 2014 630 642
25. M.N. Ajuebor, Y. Jin, and G.L. Gremillion et al. GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk J Virol 82 2008 9564 9576
26. B. Rehermann Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Nat Med 19 2013 859 868
27. L. Hammerich, F. Heymann, and F. Tacke Role of IL-17 and Th17 cells in liver diseases Clin Dev Immunol 2011 2011 345803
28. A.P. Holt, E.L. Haughton, and P.F. Lalor et al. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver Gastroenterology 136 2009 705 714
29. S. Fahey, E. Dempsey, and A. Long The role of chemokines in acute and chronic hepatitis C infection Cell Mol Immunol 11 2014 25 40
30. N. Nguyen, C. de Esch, and B. Cameron et al. Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression J Gastroenterol Hepatol 29 2014 860 869
31. D. Butera, S. Marukian, and A.E. Iwamaye et al. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C Blood 106 2005 1175 1182 (Pubitemid 41129575)
32. J.R. Larrubia, M. Calvino, and S. Benito et al. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection J Hepatol 47 2007 632 641 (Pubitemid 47503421)
33. A. Katsounas, J.F. Schlaak, and R.A. Lempicki CCL5: a double-edged sword in host defense against the hepatitis C virus Int Rev Immunol 30 2011 366 378
34. M. Coenen, and J. Nattermann The role of CCR5 in HCV infection Eur J Med Res 15 2010 97 101
35. A. Bonacchi, I. Petrai, and R.M. Defranco et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C Gastroenterology 125 2003 1060 1076 (Pubitemid 37193453)
36. J. Jiao, D. Sastre, and M.I. Fiel et al. Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression Hepatology 55 2012 244 255
37. H.M. Soo, A. Garzino-Demo, and W. Hong et al. Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES Virology 303 2002 253 277 (Pubitemid 36069190)
38. M. Zeremski, G. Hooker, and M.A. Shu et al. Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection J Hepatol 55 2011 545 553
39. E.C. Shin, S.H. Park, and M. Demino et al. Delayed induction, not impaired recruitment, of specific CD8(+) T cells causes the late onset of acute hepatitis C Gastroenterology 141 2011 686 695 695 e1
40. J.I. Riezu-Boj, E. Larrea, and R. Aldabe et al. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection J Hepatol 54 2011 422 431
41. Y.H. Oo, C.J. Weston, and P.F. Lalor et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver J Immunol 184 2010 2886 2898
42. H. Sahin, E. Borkham-Kamphorst, and N.T. do O et al. Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes Hepatology 57 2013 797 805
43. M. Zeremski, R. Dimova, and Q. Brown et al. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection J Infect Dis 200 2009 1774 1780
44. M. Zeremski, L.M. Petrovic, and L. Chiriboga et al. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C Hepatology 48 2008 1440 1450
45. A.I. Romero, M. Lagging, and J. Westin et al. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection J Infect Dis 194 2006 895 903 (Pubitemid 44454074)
46. F. Tacke, H.W. Zimmermann, and M.L. Berres et al. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases Liver Int 31 2011 840 849
47. M. Zeremski, R. Dimova, and J. Astemborski et al. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C J Infect Dis 204 2011 832 836
48. M.L. Berres, C. Trautwein, and M. Schmeding et al. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection Hepatology 53 2011 596 603
49. A. Casrouge, J. Decalf, and M. Ahloulay et al. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV J Clin Invest 121 2011 308 317
50. M. Eisenhardt, A. Glassner, and B. Kramer et al. The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C PLoS One 7 2012 e38846
51. S. Paust, H.S. Gill, B.Z. Wang, and M.P. Flynn et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses Nat Immunol 11 2010 1127 1135
52. K. Kakimi, T.E. Lane, and S. Wieland et al. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes J Exp Med 194 2001 1755 1766 (Pubitemid 34028655)
53. S.M. Keating, J.D. Heitman, and S. Wu et al. Cytokine and chemokine responses in the acute phase of hepatitis B virus replication in naive and previously vaccinated blood and plasma donors J Infect Dis 209 2014 845 854
54. C. Dunn, M. Brunetto, and G. Reynolds et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage J Exp Med 204 2007 667 680 (Pubitemid 46457088)
55. A.T. Tan, S. Koh, and W. Goh et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B J Hepatol 52 2010 330 339
56. Y. Zhou, S. Wang, and J.W. Ma et al. Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes J Biol Chem 285 2010 12159 12168
57. J. Jaroszewicz, H. Ho, and A. Markova et al. Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues Antivir Ther 16 2011 915 924
58. M.J. Sonneveld, P. Arends, and A. Boonstra et al. Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B J Hepatol 58 2013 898 903
59. J. Sanchooli, N. Sanadgol, and M. Kazemi Arababadi et al. CCR5 plays important roles in hepatitis B infection Viral Immunol 27 2014 2 6
60. B. Oliviero, A. Cerino, and S. Varchetta et al. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections J Hepatol 55 2011 53 60
61. Y. Li, S. Ma, and L. Tang et al. Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection Hepatology 58 2013 1277 1286
62. T.D. Kanneganti, and V.D. Dixit Immunological complications of obesity Nat Immunol 13 2012 707 712
63. H. Xu, G.T. Barnes, and Q. Yang et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830 (Pubitemid 38063705)
64. H. Kanda, S. Tateya, and Y. Tamori et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J Clin Invest 116 2006 1494 1505
65. K.E. Inouye, H. Shi, and J.K. Howard et al. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue Diabetes 56 2007 2242 2250 (Pubitemid 47358231)
66. E.A. Kirk, Z.K. Sagawa, and T.O. McDonald et al. Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected] Diabetes 57 2008 1254 1261
67. S. Tateya, Y. Tamori, and T. Kawaguchi et al. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice Endocrinology 151 2010 971 979
68. P. Sartipy, and D.J. Loskutoff Monocyte chemoattractant protein 1 in obesity and insulin resistance Proc Natl Acad Sci U S A 100 2003 7265 7270 (Pubitemid 36706427)
69. S.P. Weisberg, D. Hunter, and R. Huber et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding J Clin Invest 116 2006 115 124 (Pubitemid 43121796)
70. Y. Tamura, M. Sugimoto, and T. Murayama et al. C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice J Atheroscler Thromb 17 2010 219 228
71. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J Clin Invest 117 2007 175 184 (Pubitemid 46048464)
72. H. Kitade, K. Sawamoto, and M. Nagashimada et al. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status Diabetes 61 2012 1680 1690
73. B.K. Surmi, and A.H. Hasty The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue Vascul Pharmacol 52 2010 27 36
74. J. Huber, F.W. Kiefer, and M. Zeyda et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity J Clin Endocrinol Metab 93 2008 3215 3221
75. C. Rouault, V. Pellegrinelli, and R. Schilch et al. Roles of chemokine ligand-2 (CXCL2) and neutrophils in influencing endothelial cell function and inflammation of human adipose tissue Endocrinology 154 2013 1069 1079
76. C. Duffaut, A. Zakaroff-Girard, and V. Bourlier et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators Arterioscler Thromb Vasc Biol 29 2009 1608 1614
77. W. Huang, A. Metlakunta, and N. Dedousis et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance Diabetes 59 2010 347 357
78. N. Lanthier, O. Molendi-Coste, and P.D. Cani et al. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet FASEB J 25 2011 4301 4311
79. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J Clin Invest 122 2012 787 795
80. K. Miura, Y. Kodama, and S. Inokuchi et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice Gastroenterology 139 2010 323 334.e7
81. R. Stienstra, F. Saudale, and C. Duval et al. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity Hepatology 51 2010 511 522
82. Y. Nio, T. Yamauchi, and M. Iwabu et al. Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice Diabetologia 55 2012 3350 3358
83. S.J. Yang, H.B. IglayReger, and H.C. Kadouh et al. Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy Diabetologia 52 2009 972 981
84. D.Y. Oh, H. Morinaga, and S. Talukdar et al. Increased macrophage migration into adipose tissue in obese mice Diabetes 61 2012 346 354
85. J.W. Haukeland, J.K. Damas, and Z. Konopski et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 J Hepatol 44 2006 1167 1174
86. A.E. Obstfeld, E. Sugaru, and M. Thearle et al. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis Diabetes 59 2010 916 925
87. K. Miura, L. Yang, and N. van Rooijen et al. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2 Am J Physiol Gastrointest Liver Physiol 302 2012 G1310 G1321
88. C. Baeck, A. Wehr, and K.R. Karlmark et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury Gut 61 2012 416 426
89. A. Leroux, G. Ferrere, and V. Godie et al. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis J Hepatol 57 2012 141 149
90. S. Clement, C. Juge-Aubry, and A. Sgroi et al. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes Hepatology 48 2008 799 807
91. K.M. Kassel, G.L. Guo, and O. Tawfik et al. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet Lab Invest 90 2010 1794 1804
92. S. Galastri, E. Zamara, and S. Milani et al. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis Clin Sci (Lond) 123 2012 459 471
93. C.E. Egan, E.K. Daugherity, and A.B. Rogers et al. CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model PLoS One 8 2013 e65247
94. G. Kirovski, E. Gabele, and C. Dorn et al. Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation Int J Clin Exp Pathol 3 2010 675 680
95. A.E. Bigorgne, L. Bouchet-Delbos, and S. Naveau et al. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice Gastroenterology 134 2008 1459 1469
96. N. Sheron, G. Bird, and J. Koskinas et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration Hepatology 18 1993 41 46 (Pubitemid 23193615)
97. J.J. Maher Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol Am J Physiol 269 1995 G518 G523
98. Y. Shiratori, H. Takada, and Y. Hikiba et al. Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol Hepatology 18 1993 1477 1482 (Pubitemid 23348439)
99. S.C. Afford, N.C. Fisher, and D.A. Neil et al. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis J Pathol 186 1998 82 89 (Pubitemid 28407492)
100. P. Zhang, G.J. Bagby, and D.M. Boe et al. Acute alcohol intoxication suppresses the CXC chemokine response during endotoxemia Alcohol Clin Exp Res 26 2002 65 73 (Pubitemid 34093513)
101. M. Dominguez, R. Miquel, and J. Colmenero et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis Gastroenterology 136 2009 1639 1650
102. S. Affo, O. Morales-Ibanez, and D. Rodrigo-Torres et al. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis Gut 2014 Jan 20 [Epub ahead of print]
103. D. Degre, A. Lemmers, and T. Gustot et al. Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates Clin Exp Immunol 169 2012 302 310
104. P. Mandrekar, A. Ambade, and A. Lim et al. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice Hepatology 54 2011 2185 2197
105. P. Kocabayoglu, and S.L. Friedman Cellular basis of hepatic fibrosis and its role in inflammation and cancer Front Biosci (Schol Ed) 5 2013 217 230
106. D.A. Brenner, T. Kisseleva, and D. Scholten et al. Origin of myofibroblasts in liver fibrosis Fibrogenesis Tissue Repair 5 suppl 1 2012 S17
107. I. Mederacke, C.C. Hsu, and J.S. Troeger et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology Nat Commun 4 2013 2823
108. G.A. Ramm Chemokine (C-C motif) receptors in fibrogenesis and hepatic regeneration following acute and chronic liver disease Hepatology 50 2009 1664 1668
109. F. Marra, R. DeFranco, and C. Grappone et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration Am J Pathol 152 1998 423 430 (Pubitemid 28106388)
110. F. Heymann, C. Trautwein, and F. Tacke Monocytes and macrophages as cellular targets in liver fibrosis Inflamm Allergy Drug Targets 8 2009 307 318
111. F. Marra, A.J. Valente, and M. Pinzani et al. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines J Clin Invest 92 1993 1674 1680 (Pubitemid 23304529)
112. F. Marra, R.G. Romanelli, and C. Giannini et al. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells Hepatology 29 1999 140 148 (Pubitemid 29023996)
113. C. Mitchell, D. Couton, and J.P. Couty et al. Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice Am J Pathol 174 2009 1766 1775
114. E. Seki, S. de Minicis, and S. Inokuchi et al. CCR2 promotes hepatic fibrosis in mice Hepatology 50 2009 185 197
115. J. Ehling, M. Bartneck, and X. Wei et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis Gut 2014 Feb 21 [Epub ahead of print]
116. J.P. Pradere, J. Kluwe, and S. De Minicis et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice Hepatology 58 2013 1461 1473
117. E. Liaskou, H.W. Zimmermann, and K.K. Li et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics Hepatology 57 2013 385 398
118. H.W. Zimmermann, S. Seidler, and J. Nattermann et al. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis PLoS One 5 2010 e11049
119. P.S. Chu, N. Nakamoto, and H. Ebinuma et al. C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice Hepatology 58 2013 337 350
120. H.W. Zimmermann, S. Seidler, and N. Gassler et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis PLoS One 6 2011 e21381
121. B. Mosher, R. Dean, and J. Harkema et al. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury J Surg Res 99 2001 201 210 (Pubitemid 32703438)
122. A. Moles, L. Murphy, and C.L. Wilson et al. A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse J Hepatol 60 2014 782 791
123. E. Seki, S. De Minicis, and G.Y. Gwak et al. CCR1 and CCR5 promote hepatic fibrosis in mice J Clin Invest 119 2009 1858 1870
124. M.L. Berres, R.R. Koenen, and A. Rueland et al. Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice J Clin Invest 120 2010 4129 4140
125. D. Heinrichs, M.L. Berres, and A. Nellen et al. The chemokine CCL3 promotes experimental liver fibrosis in mice PLoS One 8 2013 e66106
126. R.F. Schwabe, R. Bataller, and D.A. Brenner Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration Am J Physiol Gastrointest Liver Physiol 285 2003 G949 G958
127. F. Hong, A. Tuyama, and T.F. Lee et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation Hepatology 49 2009 2055 2067
128. R. Bruno, S. Galastri, and P. Sacchi et al. gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis Gut 59 2010 513 520
129. F. Hong, Y. Saiman, and C. Si et al. X4 Human immunodeficiency virus type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4 PLoS One 7 2012 e33659
130. B.S. Ding, Z. Cao, and R. Lis et al. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis Nature 505 2014 97 102
131. H.E. Wasmuth, F. Lammert, and M.M. Zaldivar et al. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans Gastroenterology 137 2009 309 319 319 e1-e3
132. H. Sahin, E. Borkham-Kamphorst, and C. Kuppe et al. Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice Hepatology 55 2012 1610 1619
133. E. Hintermann, M. Bayer, and J.M. Pfeilschifter et al. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation J Autoimmun 35 2010 424 435
134. A. Pellicoro, P. Ramachandran, and J.P. Iredale Reversibility of liver fibrosis Fibrogenesis Tissue Repair 5 suppl 1 2012 S26
135. P. Ramachandran, A. Pellicoro, and M.A. Vernon et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis Proc Natl Acad Sci U S A 109 2012 E3186 E3195
136. J.S. Troeger, I. Mederacke, and G.Y. Gwak et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice Gastroenterology 143 2012 1073 1083.e22
137. T. Kisseleva, M. Cong, and Y. Paik et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis Proc Natl Acad Sci U S A 109 2012 9448 9453
138. F. Tacke, and H.W. Zimmermann Macrophage heterogeneity in liver injury and fibrosis J Hepatol 60 2014 1090 1096
139. C. Baeck, X. Wei, and M. Bartneck et al. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C macrophage infiltration in mice Hepatology 59 2014 1060 1072
140. M.K. Stock, L. Hammerich, and O.N. do et al. Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression Int J Clin Exp Pathol 6 2013 678 685
141. G.G. Van den Eynden, A.W. Majeed, and M. Illemann et al. The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications Cancer Res 73 2013 2031 2043
142. P. Aujla, S. Qin, and K. Price et al. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma Hepatology 30 1999 100 111 (Pubitemid 29300575)
143. Y. Ren, R.T. Poon, and H.T. Tsui et al. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis Clin Cancer Res 9 2003 5996 6001 (Pubitemid 38018086)
144. D.M. Kuang, Q. Zhao, and Y. Wu et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma J Hepatol 54 2011 948 955
145. K.H. Tang, S. Ma, and T.K. Lee et al. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling Hepatology 55 2012 807 820
146. S.L. Zhou, Z. Dai, and Z.J. Zhou et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma Hepatology 56 2012 2242 2254
147. A. Sutton, V. Friand, and S. Brule-Donneger et al. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion Mol Cancer Res 5 2007 21 33
148. Z.L. Xiang, Z.C. Zeng, and Z.Y. Tang et al. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival BMC Cancer 9 2009 176
149. W.H. Hsu, C.N. Chen, and H.I. Huang et al. Urokinase induces stromal cell-derived factor-1 expression in human hepatocellular carcinoma cells J Cell Physiol 227 2012 697 704
150. R. Zhang, X. Pan, and Z. Huang et al. Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines PLoS One 6 2011 e23831
151. V. Chew, J. Chen, and D. Lee et al. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma Gut 61 2012 427 438
152. E. Bertran, E. Crosas-Molist, and P. Sancho et al. Overactivation of the TGF-beta pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells Hepatology 58 2013 2032 2044
153. D.G. Duda, S.V. Kozin, and N.D. Kirkpatrick et al. CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res 17 2011 2074 2080
154. F. Bachelerie, G.J. Graham, and M. Locati et al. New nomenclature for atypical chemokine receptors Nat Immunol 15 2014 207 208
155. P. Lu, Y. Nakamoto, and Y. Nemoto-Sasaki et al. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas Am J Pathol 162 2003 1249 1258 (Pubitemid 36350669)
156. X. Yang, P. Lu, and C. Fujii et al. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression Int J Cancer 118 2006 1869 1876
157. L. Ochoa-Callejero, L. Perez-Martinez, and S. Rubio-Mediavilla et al. Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model PLoS One 8 2013 e53992
158. N. Iida, Y. Nakamoto, and T. Baba et al. Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alpha Cancer Res 70 2010 6556 6565
159. H. Fujii, Y. Itoh, and K. Yamaguchi et al. Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro Biochem Biophys Res Commun 322 2004 1052 1058 (Pubitemid 39164460)
160. K.J. Chen, S.Z. Lin, and L. Zhou et al. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis PLoS One 6 2011 e24671
161. P. Yang, Q.J. Li, and Y. Feng et al. TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma Cancer Cell 22 2012 291 303
162. C. Schneider, A. Teufel, and T. Yevsa et al. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer Gut 61 2012 1733 1743
163. A. Gentilini, K. Rombouts, and S. Galastri et al. Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic
164. H. Okabe, T. Beppu, and M. Ueda et al. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts Int J Cancer 131 2012 2234 2241
165. F. Hong, H. Chou, and S.L. Friedman Significant anti-fibrotic activity of cenicriviroc, a dual CCR2/CCR5 antagonist, in a rat model of thioacetamide-induced liver fibrosis and cirrhosis Hepatology 58 suppl 6 2013 1381A
166. P. Manousou, G. Kolios, and I. Drygiannakis et al. CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid Clin Exp Immunol 172 2013 9 15
167. G.E. White, A.J. Iqbal, and D.R. Greaves CC chemokine receptors and chronic inflammation-therapeutic opportunities and pharmacological challenges Pharmacol Rev 65 2013 47 89
168. T. Sullivan, Z. Miao, and D.J. Dairaghi et al. CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice Am J Physiol Renal Physiol 305 2013 F1288 F1297
169. J. Patel, K.M. Channon, and E. McNeill The downstream regulation of chemokine receptor signalling: implications for atherosclerosis Mediators Inflamm 2013 2013 459520
170. A. Ben-Baruch Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion Cell Adh Migr 3 2009 328 333